Dr Singh Gill Harinder Harry

Biography

Harry H.S. Gill joined the University of Hong Kong as Clinical Assistant Professor in July 2014. He graduated from the University of Hong Kong in 2006 and joined the Department of Medicine, Queen Mary Hospital as Resident in 2007. He completed his specialist training in Haematology and Haematological Oncology in 2013 and is Fellow of the Hong Kong College of Medicine and Hong Kong Academy of Medicine. He started his doctorate degree since 2012 with particular focus on studying genetic alterations in acute myeloid leukaemia and myelodysplastic syndromes, using both in-vitro and in-vivo experimental models. He focuses on clinical management and translational research in myeloid malignancies

Research Interest

Management of acute promyelocytic leukaemia Applications of oral arsenic trioxide in haematological malignancies Diagnosis, management and experimental therapeutics in myelodysplastic syndromes and myeloproliferative neoplasms Management and experimental therapeutics in relapsed acute myeloid leukaemia